MARKET

ECOR

ECOR

Electrocore
NASDAQ
6.17
+0.30
+5.11%
Closed 16:00 03/28 EDT
OPEN
5.86
PREV CLOSE
5.87
HIGH
6.34
LOW
5.86
VOLUME
7.52K
TURNOVER
0
52 WEEK HIGH
8.08
52 WEEK LOW
3.829
MARKET CAP
37.04M
P/E (TTM)
-1.8067
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ECOR last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at ECOR last week (0311-0315)?
Weekly Report · 03/18 11:45
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)
TipRanks · 03/15 11:40
Electrocore’s Battle with Cyber Threats: Protecting Sensitive Data Amidst Rising Security Risks
TipRanks · 03/15 06:02
Electrocore’s Growth Trajectory: A Buy Rating with Promising Prospects
TipRanks · 03/14 10:27
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 03/13 21:25
electroCore Q4 2023 GAAP EPS $(0.61), Inline, Sales $5.191M Beat $4.967M Estimate
ElectroCore (NASDAQ:ECOR) reported quarterly losses of $0.61 per share. The company reported quarterly sales of $5.191 million which beat the analyst consensus estimate of $4.967 million. ElectroCore also reported a 102.77 percent increase in sales over the same period.
Benzinga · 03/13 20:07
BRIEF-electroCore Q4 Net Income USD -4.032 Million
Reuters · 03/13 20:05
More
About ECOR
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

Webull offers electroCore, Inc. stock information, including NASDAQ: ECOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ECOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ECOR stock methods without spending real money on the virtual paper trading platform.